AI assistant
Sending…
EXOZYMES INC. — Director's Dealing 2025
Jun 20, 2025
34055_dirs_2025-06-20_7245253e-726a-4333-810f-2e284455b56e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXOZYMES INC. (EXOZ)
CIK: 0002010788
Period of Report: 2025-06-17
Reporting Person: Heltzen Michael (Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-17 | Stock Options for Common Stock | $12.40 | A | 235817 | Acquired | 2032-06-29 | Common Stock (235817) | Direct |
Footnotes
F1: The Options will vest over a four (4) year period, in equal quarterly installments at the end of each quarter of the calendar year, and the Options will commence vesting on July 1, 2025.The option expires June 29, 2032.
More from EXOZYMES INC.
Capital/Financing Update
2026
Jun 4
Capital/Financing Update
2026
May 29
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
Apr 10
Capital/Financing Update
2026
Apr 9
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Feb 5
Capital/Financing Update
2026
Jan 26
Regulatory Filings
2026
Jan 26